全文获取类型
收费全文 | 546篇 |
免费 | 39篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 47篇 |
妇产科学 | 4篇 |
基础医学 | 52篇 |
临床医学 | 36篇 |
内科学 | 272篇 |
皮肤病学 | 2篇 |
神经病学 | 4篇 |
特种医学 | 5篇 |
外科学 | 60篇 |
综合类 | 90篇 |
预防医学 | 6篇 |
眼科学 | 2篇 |
药学 | 25篇 |
中国医学 | 5篇 |
肿瘤学 | 4篇 |
出版年
2024年 | 1篇 |
2023年 | 7篇 |
2022年 | 9篇 |
2021年 | 10篇 |
2020年 | 14篇 |
2019年 | 10篇 |
2018年 | 5篇 |
2017年 | 9篇 |
2016年 | 8篇 |
2015年 | 12篇 |
2014年 | 20篇 |
2013年 | 22篇 |
2012年 | 21篇 |
2011年 | 30篇 |
2010年 | 21篇 |
2009年 | 28篇 |
2008年 | 26篇 |
2007年 | 34篇 |
2006年 | 35篇 |
2005年 | 30篇 |
2004年 | 24篇 |
2003年 | 25篇 |
2002年 | 27篇 |
2001年 | 20篇 |
2000年 | 24篇 |
1999年 | 14篇 |
1998年 | 17篇 |
1997年 | 8篇 |
1996年 | 17篇 |
1995年 | 6篇 |
1994年 | 8篇 |
1993年 | 10篇 |
1992年 | 10篇 |
1991年 | 9篇 |
1990年 | 9篇 |
1989年 | 9篇 |
1988年 | 8篇 |
1987年 | 4篇 |
1986年 | 2篇 |
1985年 | 4篇 |
1984年 | 1篇 |
1982年 | 1篇 |
1981年 | 2篇 |
1980年 | 1篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1977年 | 2篇 |
排序方式: 共有617条查询结果,搜索用时 0 毫秒
71.
U PODDAR Y CHAWLA RK DHIMAN K VAIPHEI RK VASISHTA JB DILAWARI 《Journal of gastroenterology and hepatology》1998,13(1):109-111
Ascites may be associated with fulminant hepatic failure (FHF), but spontaneous bacterial peritonitis (SBP) is an extremely rare complication. We report on two patients with FHF who developed SBP. One patient died and the other recovered. 相似文献
72.
73.
To clarify the contribution of Cblb to the development of type1 diabetes (T1D),
we investigated Japanese younger-onset T1D patients. We sequenced the cblb gene in 10 T1D
patients and screened the identified mutations in 109 Japanese T1D patients and 100 normal
subjects. In addition to four previously reported synonymous single nucleotide
polymorphisms (SNPs), we identified two novel nonsynonymous variants (786 C>T (A155V)
and 1718 A>G (N466D)). The A155V mutation was found in one subject with Basedow’s
disease whose mother also carried both the mutation and Basedow’s disease. The N466D
mutation was found in 6 T1D cases including a subject who was classified as fulminant T1D.
We found no significant differences in the allele frequency of these SNPs among T1D and
control subjects, suggesting that the contribution of cblb to the genetic susceptibility
to T1D might not be high for Japanese younger–onset T1D. 相似文献
74.
Galactosamine-induced fulminant hepatic failure rats have been used as a model for statistical assessment of liver support systems. The present study reports in detail the biochemical, hematological and histological changes in these animals. They have been used to study statistically the effects of ACAC charcoal hemoperfusion, cross-circulation and liver perfusion on long-term survival in fulminant hepatic failure. 相似文献
75.
J. A. MCDONALD P. SNITCH D. PAINTER W. HENSLEY N. D. GALLAGHER G. W. MCCAUGHAN 《Journal of gastroenterology and hepatology》1992,7(4):396-398
Two cases of acute hepatic failure are reported in which the diagnosis of Wilson's disease was considered because of low serum ceruloplasmin, low serum copper levels and high 24 h urinary copper. Case 1 had Kayser-Fleischer rings, haemolysis and a high 24 h urinary copper, and so Wilson's disease was confidently diagnosed. Case 2 had high urinary copper excretion, but [64Cu] study indicated a 24:2 h ratio of 0.7 and made the diagnosis of Wilson's disease uncertain. Both patients underwent orthotopic hepatic transplantation, and multiple biopsies were taken from the resected specimen in order to estimate hepatic copper levels. In both cases, hepatic copper levels revealed considerable variation: 0.8-5.2 mumol/g dry wt (case 1) vs 0.02-12.65 mumol/g dry wt (case 2). In case 1, only two of 14 levels were within the diagnostic range for Wilson's disease (greater than 4 mumol/g dry wt), whereas hepatic copper levels in case 2 were in the Wilsonian disease range in three of 16 specimens. These results were in contrast to uniformly high hepatic copper levels in one patient with established cirrhosis secondary to Wilson's disease and two cases of primary biliary cirrhosis. This report indicates that hepatic copper levels vary greatly in acute liver failure, and that estimates from a single biopsy specimen may be misleading as to the cause of the underlying liver disease. 相似文献
76.
77.
Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan 总被引:14,自引:0,他引:14
Mizuo H Yazaki Y Sugawara K Tsuda F Takahashi M Nishizawa T Okamoto H 《Journal of medical virology》2005,76(3):341-349
Hepatitis E in industrialized countries has not been well studied. To define the possible risk factors for transmission of hepatitis E virus (HEV) and for the severe form of hepatitis E in Japan, we investigated the clinical and virological characteristics of hepatitis E in 32 patients who contracted the mild (n=23) or severe form (n=9) of domestically acquired hepatitis E between 1996 and 2004 in Hokkaido, where hepatitis E is most prevalent in Japan. Nine patients with the severe form of hepatitis E included two patients with fulminant hepatitis E and seven patients who were diagnosed with severe acute hepatitis in which hepatic encephalopathy did not appear during the course of the illness despite low plasma prothrombin activity (or=20 mg/dl). At least 25 patients (78%) had consumed uncooked or undercooked pig liver and/or intestine 1-2 months before the onset of hepatitis E. When compared with the seven patients with HEV genotype 3, the 25 patients with HEV genotype 4 had a higher peak alanine aminotransferase (ALT) level (P=0.0338) and a lower level of lowest prothrombin activity (P=0.0340). The severe form of hepatitis E was associated with the presence of an underlying disease (56% [5/9] vs. 17% [4/23], P=0.0454). The study suggests that zoonotic food-borne transmission of HEV plays an important role in the occurrence of hepatitis E in Hokkaido, Japan, and that the HEV genotype and the presence of an underlying disease influence the severity of hepatitis E. 相似文献
78.
Son SK Oh SH Kim KM Lee YJ Jhang WK Park SJ Shin HJ Park JJ Kim TH Kim DY Hwang S Park KM Lee YJ Lee SG 《Pediatric transplantation》2012,16(7):E281-E285
Son SK, Oh SH, Kim KM, Lee YJ, Jhang WK, Park SJ, Shin HJ, Park J‐J, Kim TH, Kim DY, Hwang S, Park K‐M, Lee Y‐J, Lee S‐G. Successful liver transplantation following veno‐arterial extracorporeal membrane oxygenation in a child with fulminant Wilson disease and severe pulmonary hemorrhage: A case report. Pediatr Transplantation 2011. © 2011 John Wiley & Sons A/S. Abstract: Massive pulmonary hemorrhage and other serious cardiopulmonary diseases in patients with fulminant hepatitis result not only in graft failure but also mortality after LT. ECMO is used to treat children with cardiorespiratory failure refractory to conventional intensive care. We describe a five‐yr‐old girl with genetically confirmed fulminant Wilson disease and severe pulmonary hemorrhage who underwent successful primary LT following veno‐arterial ECMO. To our knowledge, this is the first report of successful primary LT in a patient using veno‐arterial ECMO. The present case demonstrates that ECMO, as a bridging modality to LT, may be necessary to manage both massive pulmonary hemorrhage and possible graft loss because of hypoxemia. 相似文献
79.
Ronen Arnon Rachel Annunziato Michael Schilsky Tamir Miloh Asha Willis Mark Sturdevant Arnond Sakworawich Frederick Suchy Nanda Kerkar 《Clinical transplantation》2011,25(1):E52-E60
Arnon R, Annunziato R, Schilsky M, Miloh T, Willis A, Sturdevant M, Sakworawich A, Suchy F, Kerkar N. Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults.Clin Transplant 2011: 25: E52–E60. © 2010 John Wiley & Sons A/S. Abstract: Liver transplantation (LT) is lifesaving for patients with Wilson disease (WD) presenting with fulminant hepatic failure (FHF) or chronic liver disease (CLD) unresponsive to treatment. Aim: To determine the outcome of LT in pediatric and adult patients with WD. Methods: United Network for Organ Sharing data on LT from 1987 to 2008 were analyzed. Outcomes were compared for patients requiring LT for FHF and CLD after 2002. Multivariate logistic regression was used to determine risk factors for death and graft loss. Results: Of 90 867 patients transplanted between 1987 and 2008, 170 children and 400 adults had WD. The one‐ and five‐yr patient survival of children was 90.1% and 89% compared to 88.3% and 86% for adults, p = 0.53, 0.34. After 2002, 103 (41 children) were transplanted for FHF and 67 (10 children) for CLD. One‐ and five‐yr patient survival was higher in children transplanted for CLD compared to FHF; 100%, 100% vs. 90%, 87.5% respectively, p = 0.30, 0.32. One‐ and five‐yr patient survival was higher in adults transplanted for CLD compared to FHF; 94.7%, 90.1% vs. 90.3%, 89.7%, respectively, p = 0.36, 0.88. Encephalopathy, partial graft, and ventilator use were risk factors for death by logistic regression. Conclusion: LT is an excellent treatment option for patients with WD. Patients transplanted for CLD had higher patient survival rates than patients with FHF. 相似文献
80.
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience 总被引:6,自引:0,他引:6
Tillmann HL Hadem J Leifeld L Zachou K Canbay A Eisenbach C Graziadei I Encke J Schmidt H Vogel W Schneider A Spengler U Gerken G Dalekos GN Wedemeyer H Manns MP 《Journal of viral hepatitis》2006,13(4):256-263
Acute hepatitis B progresses to liver failure with the need of liver transplantation in about 1% of cases. We treated patients with severe acute or fulminant hepatitis B with lamivudine in an attempt to prevent hepatitis B virus (HBV) reinfection after potential liver transplantation. Since September 2000, 17 patients with severe acute or fulminant HBV infection were treated with 100 or 150 mg lamivudine daily once we had evidence for a severe course as indicated by an INR >2.0. These were compared to a historic control from our unit and to external patients. Fourteen of the 17 patients (82.4%) survived with full recovery without liver transplantation. All these 14 individuals cleared HBsAg on lamivudine within less than 6 months. Twelve patients recovered quickly as indicated by a normalized prothrombin time within 1 week while two patients had a more prolonged course. None of the patients showed an adverse event. Three patients requiring transplantation despite lamivudine therapy had more advanced disease on admission, of whom one had additionally ingested paracetamol (acetaminophen) while the second was already HBV-DNA negative by polymerase chain reaction on admission. The lamivudine treated patients had significant higher frequency of survival without liver transplantation 82.4 vs 20% (4/20) in the historic control (P < 0.001). Similar data were derived from external centres using lamivudine (15/20, 75%). Lamivudine is safe in patients with severe acute or fulminant hepatitis B, leading to fast recovery with the potential to prevent liver failure and liver transplantation when administered early enough. 相似文献